Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.
Karin Leiderman1, William C Chang1, Mikhail Ovanesov1
1From the Department of Applied Mathematics and Statistics, Colorado School of Mines, Golden (K.L.); Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD (W.C.C., M.O.); and Departments of Mathematics and Bioengineering, University of Utah, Salt Lake City (A.L.F.).
Low concentrations of tissue factor (TF) and exogenous factor XIa (FXIa) synergize to significantly increase thrombin generation. This interaction, crucial for understanding thrombosis, involves distinct mechanisms and binding sites.
Area of Science:
- Biochemistry
- Hematology
- Thrombosis Research
Background:
- Coagulation factor XIa (FXIa) is implicated in thrombotic events.
- Tissue factor (TF) plays a key role in initiating coagulation.
Purpose of the Study:
- To investigate potential synergistic effects between TF and exogenous FXIa (E-FXIa) on thrombin generation.
- To elucidate the mechanisms underlying TF-FXIa synergy in thrombin burst formation.
Main Methods:
- Thrombin generation assays were performed using varying concentrations of TF and E-FXIa.
- Mathematical modeling (in silico simulations) was employed to analyze thrombin generation dynamics.
- Platelet-bound factor IX (FIX) and factor VIIIa (FVIIIa) activation pathways were examined.
Main Results:
- E-FXIa significantly increased peak thrombin and decreased lag time at low TF concentrations, but not at high TF levels.
- Synergistic action of TF and E-FXIa induced thrombin bursts at much lower TF levels than TF alone.
- Distinct mechanisms, including sustained activation of platelet-bound FIX by E-FXIa, were required for TF-E-FXIa synergistic bursts.
- Different platelet FIX/FIXa binding sites were involved in bursts initiated by high TF versus low TF with E-FXIa.
Conclusions:
- Low concentrations of TF and E-FXIa exhibit synergy, leading to substantial thrombin production.
- The identified differences in FIX/FIXa binding sites may offer therapeutic targets for thrombotic disorders.
More Related Videos
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Clot Retraction and Fibrinolysis
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

